- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04753242
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Background:
The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.
Objectives:
The aims of this international online survey are
- To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
- To assess the experiences made with the established services so far.
- To assess the need for networking, cooperation and support.
- Improvement of psychosocial care in acute hospitals in the context of pandemics.
Study Design:
This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.
There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).
Ethic approval:
In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.
Setting:
The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.
Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.
Country specific regions:
The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.
Online survey questionnaire:
Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.
The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
-
Ghent, Belgien
- Ghent University Hospital, Department of Psychiatry
-
-
-
-
Bayern
-
Nürnberg, Bayern, Deutschland, 90419
- Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
-
-
Nordrhein-Westfalen
-
Köln, Nordrhein-Westfalen, Deutschland, 50937
- University Hospital Cologne, Department of Psychosomatics and Psychotherapy
-
-
-
-
-
Oulu, Finnland, 90220
- Oulu University Hospital and University of Oulu
-
-
-
-
-
Paris, Frankreich
- Université de Paris, Service de Psychiatrie de l'adulte
-
-
-
-
-
Thessaloniki, Griechenland
- Aristotle University Thessaloniki
-
-
-
-
-
Tehran, Iran, Islamische Republik
- University of Medical Sciences, Department of Psychiatry
-
-
-
-
-
Dublin, Irland
- University College Dublin
-
-
-
-
-
Bologna, Italien, 40123
- Bologna University
-
Modena, Italien, 411274
- University of Modena & Reggio Emilia
-
-
-
-
-
Montreal, Kanada
- University of Montreal, Department of Psychosomatic Medicine
-
Toronto, Kanada
- TorontoSinai Health, University of Toronto, Department of Psychiatry
-
-
-
-
-
Oslo, Norwegen
- Oslo University Hospital
-
-
-
-
-
Wroclaw, Polen
- Wroclaw Medical University
-
-
-
-
-
Lisboa, Portugal
- Hospital de Santa Maria
-
Lisboa, Portugal
- Universidade Católica Portuguesa Lisboa
-
-
-
-
-
Basel, Schweiz, 4002
- University of Basel, Department of Psychiatry (UPK)
-
-
Basel-City
-
Basel, Basel-City, Schweiz, 4031
- University Hospital Basel, Department of Psychosomatic Medicine
-
-
-
-
-
Barcelona, Spanien
- Barcelona University
-
-
-
-
-
Exeter, Vereinigtes Königreich
- University of Exeter
-
York, Vereinigtes Königreich
- University of York
-
-
-
-
Steiermark
-
Graz, Steiermark, Österreich, 8036
- Medical University of Graz, University Hospital Graz
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries
Exclusion Criteria:
- None
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Structural and process quality of COVID-19 related psychosocial C&L services
Zeitfenster: 6 months
|
Data basis for improving quality of COVID-19 related psychosocial C&L services:
|
6 months
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- Req-2020-00861; th21Schaefert
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Covid-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios...AbgeschlossenPostakute Folgen von COVID-19 | Zustand nach COVID-19 | Lang-COVID | Chronisches COVID-19-SyndromItalien
-
Yang I. PachankisAktiv, nicht rekrutierendCOVID-19 Atemwegsinfektion | COVID-19 Stresssyndrom | COVID-19-Impfstoff-Nebenwirkung | COVID-19-assoziierte Thromboembolie | COVID-19 Post-Intensive-Care-Syndrom | COVID-19-assoziierter SchlaganfallChina
-
Indonesia UniversityRekrutierungPost-COVID-19-Syndrom | Lange COVID | Zustand nach COVID-19 | Post-COVID-Syndrom | Lange COVID-19Indonesien
-
Massachusetts General HospitalRekrutierungPostakutes COVID-19-Syndrom | Lange COVID | Postakute Folgen von COVID-19 | Lange COVID-19Vereinigte Staaten
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRekrutierungCovid-19 Pandemie | Covid-19 Impfungen | COVID-19-ViruskrankheitIndonesien
-
Endourage, LLCRekrutierungLange COVID | Lange Covid19 | Postakutes COVID-19 | Langstrecken-COVID | Langstrecken-COVID-19 | Postakutes COVID-19-SyndromVereinigte Staaten
-
University Hospital, Ioannina1st Division of Internal Medicine, University Hospital of IoanninaRekrutierungCOVID-19 Lungenentzündung | COVID-19 Atemwegsinfektion | Covid-19 Pandemie | COVID-19 akutes Atemnotsyndrom | COVID-19-assoziierte Pneumonie | COVID-19-assoziierte Koagulopathie | COVID-19 (Coronavirus-Krankheit 2019) | COVID-19-assoziierte ThromboembolieGriechenland
-
Sheba Medical CenterUnbekannt
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNoch keine RekrutierungPost-COVID-19-Syndrom | Lange COVID | Lange Covid19 | Zustand nach COVID-19 | Post-COVID-Syndrom | Post-COVID-19-Zustand, nicht näher bezeichnet | Post-COVID-ZustandNiederlande
-
Michael Peluso, MDAerium Therapeutics; Patient-Led Research Collaborative; PolyBio Research FoundationAktiv, nicht rekrutierendLange COVID | Postakutes COVID-19 | Postakute Folgeerscheinungen von COVID-19Vereinigte Staaten
Klinische Studien zur Online survey questionnaire
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...AbgeschlossenDiabetes mellitus, Typ 2Vereinigte Staaten
-
Fatih Sultan Mehmet Training and Research HospitalAktiv, nicht rekrutierendCOVID-19 | Lifestyle-FaktorenTruthahn
-
Massachusetts General HospitalShriners Hospitals for ChildrenAbgeschlossenVerbrennungen | TraumaVereinigte Staaten
-
Yale UniversityFood and Drug Administration (FDA)Aktiv, nicht rekrutierendLebensqualität | Lymphom | Krebs, Brust | Physische Funktion | Patientenermächtigung | PatientenaufklärungVereinigte Staaten
-
University of OxfordAbgeschlossenVerwendung von AntibiotikaThailand
-
AIDS Arms Inc.AbgeschlossenHIV-1 | AIDSVereinigte Staaten
-
Istinye UniversityAbgeschlossenLebensqualität | Physische Aktivität | SchlafqualitätTruthahn
-
Assiut UniversityUnbekannt
-
Medical University of LublinAbgeschlossen
-
Saglik Bilimleri UniversitesiNoch keine Rekrutierung